MBE Wealth Management’s CVS Health CVS Stock Holding History

MBE Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-891	Closed	-$52K	–	145
2020 Q1	$52K	Buy	+891	New	+$59.5K	0.05%	118

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

MBE Wealth Management's CVS Position: Q2 2020 in Review

MBE Wealth Management sold out of CVS Health (CVS) in Q2 2020, closing a stake of 891 shares — an estimated $52K sold.

MBE Wealth Management first reported a position in CVS in Q1 2020 and held it in 1 quarter. The position peaked at $52K in Q1 2020. 1,864 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

MBE Wealth Management reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
MBE Wealth Management sold 891 CVS Health shares in Q2 2020, an estimated $52K.
MBE Wealth Management first reported a position in CVS Health in Q1 2020 and held it in 1 quarter.
MBE Wealth Management's CVS Health position peaked at $52K in Q1 2020.
1,864 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on MBE Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.